Literature DB >> 32008255

Effects of Surgical and Non-surgical Weight Loss on Migraine Headache: a Systematic Review and Meta-Analysis.

Angelo Di Vincenzo1, Marco Beghetto1, Roberto Vettor1, Claudio Tana2, Marco Rossato1, Dale S Bond3, Claudio Pagano4.   

Abstract

BACKGROUND: The aim of this study was to perform a meta-analysis on the effect of weight loss obtained by bariatric surgery or behavioral intervention on migraine frequency and indices of severity.
MATERIALS AND METHODS: A search through Pubmed/Medline, ISI-web of knowledge, and Google Scholar retrieved 10 studies (n = 473). Selected outcomes were Headache Frequency, Pain Severity, Disability, and Attack Duration while BMI, BMI change, type of intervention (bariatric vs. behavioral), and type of population (adult vs. pediatric) were used for moderators and meta-regression analysis.
RESULTS: Random effect meta-analysis shows that weight loss yields significant reductions in Headache Frequency (ES - 0.78, p < 0.0001), Pain Severity (ES - 1.04, p < 0.0001), Disability (ES -0.68, p < 0.0001), and Attack Duration (ES - 0.25, p = 0.017). Improvement in migraine was not correlated either to the degree of obesity at baseline or the degree of weight reduction. The effect on migraine was similar when weight reduction was obtained with bariatric surgery or behavioral intervention and was comparable in adult and pediatric populations.
CONCLUSIONS: Weight loss improves characteristics of migraine headache in patients who have obesity independently of the type of intervention and the amount of weight loss. The mechanisms underlying the link between obesity, weight loss, and migraine headache may include chronic inflammation, obesity comorbidities, and overlapping behavioral and psychological risk factors.

Entities:  

Keywords:  Bariatric; Migraine; Obesity; Weight loss

Mesh:

Year:  2020        PMID: 32008255     DOI: 10.1007/s11695-020-04429-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  7 in total

1.  Bariatric Surgery in Migraine patients: CGRP Level and Weight Loss.

Authors:  Helia Hemasian Etefagh; Shahab Shahabi Shahmiri; Hamid Melali; Masoud Sayadi; Hossein Ansari; Arvin Shahzamani; Mitra Sadat Deyhimi
Journal:  Obes Surg       Date:  2022-08-03       Impact factor: 3.479

Review 2.  A Bidirectional View of Migraine and Diet Relationship.

Authors:  Parisa Gazerani
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-11       Impact factor: 2.570

3.  A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study.

Authors:  Torsten Schröder; Gianna Kühn; Anna Kordowski; Soodeh Razeghi Jahromi; Astrid Gendolla; Stefan Evers; Charly Gaul; Diamant Thaçi; Inke Regina König; Christian Sina
Journal:  J Clin Med       Date:  2022-02-20       Impact factor: 4.241

Review 4.  Applying a biopsychosocial model to migraine: rationale and clinical implications.

Authors:  Chiara Rosignoli; Raffaele Ornello; Agnese Onofri; Valeria Caponnetto; Licia Grazzi; Alberto Raggi; Matilde Leonardi; Simona Sacco
Journal:  J Headache Pain       Date:  2022-08-11       Impact factor: 8.588

5.  Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes.

Authors:  Mariarosaria Valente; Riccardo Garbo; Francesca Filippi; Alice Antonutti; Veronica Ceccarini; Yan Tereshko; Cherubino Di Lorenzo; Gian Luigi Gigli
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

6.  Dietary ω-3 intake for the treatment of morning headache: A randomized controlled trial.

Authors:  Marco Marchetti; Paola Gualtieri; Antonino De Lorenzo; Domenico Trombetta; Antonella Smeriglio; Mariarosaria Ingegneri; Rossella Cianci; Giulia Frank; Giulia Schifano; Giulia Bigioni; Laura Di Renzo
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

Review 7.  Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus.

Authors:  Eduardo Rivera-Mancilla; Linda Al-Hassany; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.